Global publisher Springer Nature has announced that it will publish npj Precision Oncology, a new open access, international, peer-reviewed journal, in partnership with The Hormel Institute University of Minnesota in Austin, Minnesota, United States. Dr. Zigang Dong, Executive Director of the Hormel Institute and leader of the institute's molecular and cellular biology research section, and Dr. Ann Bode, Associate Director of the Hormel Institute and leader of the institute's cancer biomarkers and drug resistance research section, will serve as joint Editors-in-Chief of the journal.
npj Precision Oncology will publish cutting edge scientific research in all aspects of precision oncology, from basic science to translational applications to clinical medicine. Additionally, the journal will also publish case reports, brief communications, commentaries, perspectives, and review articles. Each original research article will include a lay summary that will summarize the key issues with the goal of maximising the impact and reach of the research findings.
The journal is currently open for submissions. It is expected to launch its first content at the end of 2016.
Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
